ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP)
申请人:AstraZeneca AB
公开号:EP1274697A1
公开(公告)日:2003-01-15
[EN] ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP)<br/>[FR] ARYLPIPERAZINES ET LEUR UTILISATION EN TANT QU'AGENTS INHIBANT LES METALLOPROTEINASES (MMP)
申请人:ASTRAZENECA AB
公开号:WO2001062750A1
公开(公告)日:2001-08-30
Compounds of formula (I) wherein Z is -CH2SR and R represents hydrogen or -COCH3, are useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
Arylpiperazines and their use as metallaproteinase inhibiting agents (mmp)
申请人:——
公开号:US20030100548A1
公开(公告)日:2003-05-29
1
Compounds of formula (I) wherein Z is —CH2SR and R represents hydrogen or —COCH
3
, are useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.